NEO-PV 01

N/A

Report date: 2023/05/05 17:38:36

Base Information

Drug NameNEO-PV 01
Drug Alias NameNeoantigen-based vaccineNeoVaxNEO-PV-01
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsSkin MelanomaUrinary Bladder NeoplasmsCarcinoma, Non-Small-Cell Lung +[11] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesDana-Farber Cancer InstituteBroad Institute
China Registration ClassN/A

Develop Information

Active CompaniesDana-Farber Cancer Institute
Inactive CompaniesBioNTech US Inc
Active IndicationsSkin MelanomaOvarian NeoplasmsMelanoma +[6] 
Inactive IndicationsUrinary Bladder NeoplasmsCarcinoma, Non-Small-Cell LungLung Neoplasms +[5] 

Other Information

ATC CodeN/A
Related LinksN/A